Special Issues
Pharmaceuticals publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Antihypertensive Drugs
Deadline: 30 November 2009
Interferons
Deadline: 30 November 2009
Personalized Medicine
Deadline: 31 December 2009
Targeted Therapy
Deadline: 28 February 2010
Antibiotics
Deadline: 31 March 2010
Antiepileptic Drugs
Deadline: 30 April 2010
Allosteric Modulation
Deadline: 30 June 2010
Cannabinoids
Deadline: 30 June 2010
Non-Steroidal Anti-Inflammatory Drugs
Deadline: 30 August 2010
Antidepressants
Deadline: 31 October 2010
New Antimalarial Drugs
Deadline: 30 November 2010
Opioids
Deadline: 15 December 2010
of 84

